Merit Medical acquires View Point Medical for ~$140M; 2027 non-GAAP EPS accretive

MERIT MEDICAL SYSTEMS INC

Total consideration ~$140M; $90M cash at closing, $25M deferred at each of first and second anniversaries.
View Point's OneMark System complements Merit's SCOUT platform for breast lesion localization.
Projected 2026 revenue $2M-$4M, dilutive to non-GAAP EPS by ~$0.05.
Projected 2027 revenue $14M-$16M, accretive to non-GAAP EPS; 20%+ growth, 70% non-GAAP gross margins.
Q1 2026 earnings call scheduled for April 30, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.